onctalk 2021 - extrapolating across molecular markers in the curative setting
Published 2 years ago • 18 plays • Length 4:21Download video MP4
Download video MP3
Similar videos
-
2:29:17
december 11, 2021 - onctalk 2021 full video available on demand
-
4:53
onctalk 2021 - testing in potentially resectable nsclc and unresectable locally advanced nsclc
-
16:39
gracecast-067_lung-cancer_expert round table - nsclc molecular markers case 3
-
25:07
gracecast-101_lung-cancer_mm in lc pt6: dr. goss on incorporating markers across a hc system
-
35:02
gracecast-039_lung-cancer_pennell nsclc molecular markers webinar
-
2:22:00
onctalk 2022 -- on demand full video
-
1:45
gracecastuc-076_lung_utility of molecular marker results in adjuvant setting for early stage nsclc
-
9:01
gracecast-040_lung-cancer_horton interview 3 - molecular markers
-
4:11
molecular testing: liquid vs. tissue, and insurance coverage - lung cancer onctalk 2022
-
3:58
onctalk 2021 - broad testing in stage iii unresectable disease
-
20:06
gracecast-065_lung-cancer_expert round table - nsclc molecular markers
-
1:45
gracecastuc-048_lung_what molecular markers do you prioritize for adv. nsclc, and who to test?
-
2:22
aegean trial: perioperative durvalumab for nsclc - onctalk lung 2023
-
2:30
advances in oligometastatic disease - onctalk lung 2023
-
3:53
identifying smoldering multiple myeloma patients: risk factors - blood cancer onctalk 2023
-
1:23
gracecastuc-067_lung_dr. goldberg on utility of molecular marker results in the adjuvant setting
-
9:36
gracecast-021_lung-cancer_stage iiia management options